NEW YORK (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy ...
The nation’s biggest pharmacy benefits manager has decided to cover two new drugs that lower artery-clogging cholesterol but raise concern over prices that can top $14,000 a year. Express Scripts said ...
Dec 22 (Reuters) - The nation's largest pharmacy benefit manager has lined up a cheaper price from AbbVie Inc on its newly approved hepatitis C treatment and, in most cases, will no longer cover ...
The nation’s largest pharmacy benefit manager said Tuesday it’s not going to try to bring down costs by forcing the makers of two pricey new cholesterol drugs to compete against each other, as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results